Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...

Details from two large trials of Novo Nordisk’s GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...

Altimmune, Inc. nears key MASH data for pemvidutide—learn investor risks, potential rewards, and what the upcoming results ...

Hims & Hers Health announced its expansion into Canada on Thursday, sending Hims stock higher in early action.

Novo Nordisk A/S left open the door for additional work on its pill version of Ozempic for Alzheimer’s disease after a pair ...

Q. I was on a 14-day course of prednisone for vertigo. Once I stopped, I had terrible withdrawal symptoms that have persisted for more than 10 days.

The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. What Happens If You Use Expired Semaglutide? Wondering what ...

The ADDF has long championed a research strategy that targets the full pathobiology of Alzheimer's, and invested early in science that laid the groundwork for the Evoke trials, providing nearly $1 ...

GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...

Tom Nolan reviews this week’s research Social media platforms are awash with influencers promoting cures for all ills. They often make claims that would breach advertising rules—particularly in the ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...